Delivery Order SPE2DB22D2007-SPE2DB25FH6RT
Award Date
10/31/24
Potential Completion Date
11/22/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $8,933.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm-fixed-price delivery order is for the supply of the medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is a Firm Fixed Price Delivery Order for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The award has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,241.86 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of February 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,466.57 Firm Fixed Price Delivery Order is for the supply of the prescription drug ZEPOSIA 0.92 MG CAPSULE 30S. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm fixed-price delivery order is for the provision of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $13,399.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication, to support federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,466.57 firm fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract valued at $8,933.14 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product ZEPOSIA 0.92 MG CAPSULE 30S. This award is under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies...